You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site

Continue

Go back

Popup

Request a medical representative

About Avamys

Avamys nasal spray is indicated for the treatment of the symptoms of allergic rhinitis in adults and adolescents from 12 years of age and for children from 2 to 11 years of age.

Click to learn more

Indication

Meet the Avamys patients

The symptoms of allergic rhinitis can affect patients at different stages of their lives.

Meet the patients

Efficacy

Efficacy

How does Avamys compare with a conventional nasal spray (fluticasone propionate)?

Read more

Patient resources

Resources for your Avamys patients

‘How To’ guide and other useful information for patients who have been prescribed Avamys

Find out more

Video player requires JavaScript enabled. You can download this video here: http://edgesuite.gskstatic.com/HealthSites/Health/Nigeria/MP4/Products/Avamys/AvamysShortVideo.mp4

 

Indications

The Avamys device; A patient-friendly, easy-to-use device

Avamys (fluticasone furoate) is delivered via a patient-friendly, easy-to-use device that patients prefer

Watch the video

Indication

The unified airway

Up to 80% of asthma patients have allergic rhinitis

Watch video on the link between Asthma and allergic rhinitis

Journal Updates

Avamys is a trademark of GlaxoSmithKline group of companies.
To report an Adverse Event, please contact the toll-free line 0800 CALL GSK (0800 2255 475) or send an email.